IssuerAnnouncementDetailsV2Portlet
Actions
Jamjoom Pharmaceuticals Factory Co. Announces Contract Sign Off with Local Content & Government Procurement Authority
| Element List | Explanation |
|---|---|
| Introduction | Jamjoom Pharmaceuticals Factory Company Announces Contract Sign Off with The Local Content & Government Procurement Authority |
| Date of Announcement of the Award | 2024-01-29 Corresponding to 1445-07-17 |
| Contract Subject Matter | the Localization of Pharmaceutical product “Sitagliptin Phosphate” for inclusion in the Mandatory List |
| The Entity with Which the Contract was Signed | Local Content & Government Procurement Authority |
| Date of Signing the Contract | 2024-01-29 Corresponding to 1445-07-17 |
| Contract Value | Not Applicable |
| Contract Details | The Company and Local Content & Government Procurement Authority signed a Contract for the Localization and technology transfer of pharmaceutical product (Sitagliptin Phosphate), that is used as treatment for type 2 diabetes. |
| Contract Duration | 3 Years from effective date of the contract |
| Financial Impact and the Relevant Period | The financial impact is not possible to be determined at this stage |
| Related Parties | no related parties involved |
| Additional Information | The Company would like to affirm that the contract is in-line with Company’s strategy in enhancing sustainable partnerships with the Government sector, which will also contribute to achieving the Kingdom Vision of 2030 by increasing the localization of pharmaceutical manufacturing. Manufacturing and commercialization of the product under the contract will take place upon obtaining the necessary authority approvals. |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
Share
Company Performance
Key Parameters
Last Price 153.4
Net Change -0.9 (-0.58%)
Value Traded (Sar) 6,116,632.9
Volume Traded 39,813
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions